Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Antineoplastic agents 365. Dolastatin 10 SAR probes
George R. Pettit
, Jayaram K. Srirangam
, Jozsef Barkoczy
, Michael D. Williams
, Michael R. Boyd
, Ernest Hamel
, Robin K. Pettit
, Fiona Hogan
, Ruoli Bai
, Jean Charles Chapuis
,
Shane C. McAllister
, Jean M. Schmidt
Pediatric Hematology/Oncology
Research output
:
Contribution to journal
›
Article
›
peer-review
82
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Antineoplastic agents 365. Dolastatin 10 SAR probes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antineoplastic Agents
100%
Dolastatin 10
100%
Structural Modification
75%
Phase I Clinical Trial
25%
Cancer Cell Lines
25%
Anticancer Drugs
25%
Vinblastine
25%
Tubulin
25%
Tubulin Polymerization
25%
Parent Compounds
25%
Indian Ocean
25%
Antifungal Activity
25%
Forficula Auricularia
25%
Sea Hare
25%
GTP Binding
25%
Antibacterial Activity
25%
Pharmacology, Toxicology and Pharmaceutical Science
Structure Activity Relationship
100%
Dolastatin 10
100%
Antineoplastic Agent
100%
Tubulin
50%
Clinical Trial
25%
Antibacterial Activity
25%
Antifungal Activity
25%
Dolabella auricularia
25%
Sea Hare
25%
Malignant Neoplasm
25%
Anticarcinogen
25%
Vinblastine
25%
Guanosine Triphosphate
25%